SPECT exams fell sharply in first wave of pandemic
January 18, 2021 -- An 80% drop in the volume of SPECT myocardial perfusion imaging studies occurred in spring 2020 as nonessential procedures were postponed, according to a report published by the European Journal of Nuclear Medicine and Molecular Imaging.  Discuss
What impact will Brexit deal have on radiology?
January 5, 2021 -- The protracted political, economic, and regulatory game of chess played by London and Brussels finally came to an end when the U.K. and European Union's Trade and Cooperation Agreement was signed on 24 December. Market columnist Steve Holloway assesses the implications of the Brexit deal.  Discuss
PET/CT can boost outcome in hyperparathyroidism cases
December 15, 2020 -- Using a combination of several modalities, including PET/CT, to achieve an accurate diagnosis is vital to reduce the likelihood of surgical failure and the risk of complications in cases of persistent or recurrent primary hyperparathyroidism, researchers from a leading London facility have reported.  Discuss
Nuclear medicine copes with upheaval in pandemic
December 15, 2020 -- At one point this year, it looked like Europe's entire nuclear medicine sector would have to be put on hold, said Antonis Kalemis, PhD, president of Nuclear Medicine Europe. When COVID-19 began spreading rapidly, industry felt huge anxiety as the lockdown measures escalated, but it has pulled together and survived.  Discuss
What's new in noninvasive detection of skin cancer?
November 27, 2020 -- Researchers from Israel have developed and tested a fiberoptic evanescent wave spectroscopy system that can noninvasively identify and characterize skin cancers. They successfully identified cancerous lesions on patients' skin by touching the suspicious regions for 30 seconds with an optical fiber connected to a mid-infrared spectrometer.  Discuss
Total-body PET can prove a game changer
November 25, 2020 -- Higher image quality, lower patient and staff radiation exposure, simultaneous multiorgan imaging, and expanded range for optimal dose imaging are among the significant advantages that total-body PET can bring to the clinical setting, according to a leading hybrid imaging expert.  Discuss
German team unveils progress in pancreatic cancer staging
November 4, 2020 -- Investigators from Heidelberg University Hospital and the German Cancer Research Center are convinced that PET/CT using a fibroblast activation protein molecule inhibitor can open up new applications in staging and restaging of pancreatic ductal adenocarcinoma.  Discuss
Dutch use molecular scan to find new salivary glands
October 30, 2020 -- A group from the Netherlands Cancer Institute in Amsterdam has used PET/CT with a radiopharmaceutical based on a prostate-specific membrane antigen to discover a pair of salivary glands. Sparing these glands during radiation therapy may prevent treatment side effects and improve quality of life for head and neck cancer patients.  Discuss
PET/CT rules supreme in cases of neuroendocrine tumors
October 27, 2020 -- PET/CT has no rivals when it comes to the detection and surveillance of cardiac metastases in well-differentiated gastroenteropancreatic neuroendocrine tumors as well as guiding clinical management, according to research presented at the annual congress of the European Association of Nuclear Medicine.  Discuss
Dynamic PET edges closer to clinical prime time
October 27, 2020 -- Dynamic whole-body PET is evolving fast and showing considerable clinical promise, a leading French molecular imaging expert told the opening plenary session at the annual congress of the European Association of Nuclear Medicine. The technique is benefiting from artificial intelligence-based assistance to simplify the challenging and time-consuming tasks associated with the acquisition and analysis of data.  Discuss